Skip to content
The Policy VaultThe Policy Vault

StreptomycinCareFirst (Caremark)

Mycobacterium tuberculosis infection (used as part of a multi-drug regimen with INH, rifampin, and pyrazinamide or if other drugs are contraindicated)

Initial criteria

  • Use for infections caused by susceptible strains only
  • For tuberculosis, reserve as fourth drug unless resistance likelihood is low
  • Reassess need for fourth drug once susceptibility results are available
  • Seek expert consultation for complex resistance or HIV coinfection